IA
LFCR icon

Icon Advisers’s Lifecore Biomedical LFCR Stock Holding History

Icon Advisers’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,100
Closed -$238K – 363
2015
Q4 		$238K Sell
20,100
-209,300
-91% -$2.57M 0.02% 342
2015
Q3 		$2.68M Hold
229,400
– – 0.18% 144
2015
Q2 		$3.31M Hold
229,400
– – 0.21% 123
2015
Q1 		$3.2M Hold
229,400
– – 0.19% 125
2014
Q4 		$3.17M Sell
229,400
-93,500
-29% -$1.21M 0.19% 127
2014
Q3 		$3.96M Buy
322,900
+156,200
+94% +$1.95M 0.23% 113
2014
Q2 		$2.08M Buy
166,700
+85,000
+104% +$1M 0.13% 140
2014
Q1 		$912K Buy
81,700
+80,000
+4,706% +$878K 0.07% 211
2013
Q4 		$21K Buy
+1,700
New +$20.3K ﹤0.01% 290

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Icon Advisers's LFCR Position: Q1 2016 in Review

Icon Advisers sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 20,100 shares — an estimated $238K sold.

Icon Advisers first reported a position in LFCR in Q4 2013 and held it in 9 quarters. The position peaked at $3.96M in Q3 2014. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

  • Icon Advisers reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
  • Icon Advisers sold 20,100 Lifecore Biomedical shares in Q1 2016, an estimated $238K.
  • Icon Advisers first reported a position in Lifecore Biomedical in Q4 2013 and held it in 9 quarters.
  • Icon Advisers's Lifecore Biomedical position peaked at $3.96M in Q3 2014.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Icon Advisers's 13F filing for Q1 2016, filed 5 May 2016.